|
|
|
Volumn 17 Suppl 5 Improving, Issue , 2011, Pages
|
|
Functional improvement and symptom management in multiple sclerosis: clinical efficacy of current therapies.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BETA INTERFERON;
CORTICOSTEROID;
GLATIRAMER;
IMMUNOSUPPRESSIVE AGENT;
MITOXANTRONE;
MONOCLONAL ANTIBODY;
NATALIZUMAB;
PEPTIDE;
DAILY LIFE ACTIVITY;
DISABLED PERSON;
DISEASE COURSE;
HEALTH SERVICE;
HUMAN;
MULTIPLE SCLEROSIS;
NEUROLOGIC DISEASE;
PATHOLOGY;
PSYCHOLOGICAL ASPECT;
QUALITY OF LIFE;
REVIEW;
WALKING DIFFICULTY;
ACTIVITIES OF DAILY LIVING;
ADRENAL CORTEX HORMONES;
ANTIBODIES, MONOCLONAL, HUMANIZED;
ANTINEOPLASTIC AGENTS;
DISABLED PERSONS;
DISEASE PROGRESSION;
GAIT DISORDERS, NEUROLOGIC;
HEALTH SERVICES NEEDS AND DEMAND;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INTERFERON-BETA;
MITOXANTRONE;
MOBILITY LIMITATION;
MULTIPLE SCLEROSIS;
PEPTIDES;
QUALITY OF LIFE;
|
|
EID: 84855730898
PISSN: None
EISSN: 19362692
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (28)
|
|
References (0)
|
